Mexico is One Step Closer to Cannabis Regulation in 2022 March 01, 2022 - Baystreet.ca Mexico may be closer to cannabis regulation. While 2021 ended the Mexican Senate passing new cannabis laws, “the President of the Mexican Senate Olga Sánchez Cordero Dávila tweeted hat she was ready to move forward with marijuana regulation along with a number of other priorities during the current legislative session. “We will work to approve the initiatives that we have presented in matters of cannabis regulation,” as quoted by The Paper. She added, “I have just been informed that even Thailand, in the Asian countries, has already approved the regulation of cannabis. Of course, already in many other countries they are regulating it, and we do not want to be left behind,” as quoted by Mugglehead Magazine. With Mexico nearing potential legislation, it could be a substantial catalyst for Xebra Brands (CSE:XBRA) (OTCQB:XBRAF), Aurora Cannabis (NASDAQ:ACB) (TSX:ACB), Canopy Growth (TSX:WEED)(NASDAQ:CGC), Tilray Inc. (NASDAQ:TLRY)(TSX:TLRY), and OrganiGram Holdings (NASDAQ:OGI)(TSX:OGI). Look at Xebra Brands (CSE:XBRA)(OTCQB:XBRAF), For Example Xebra Brands Ltd., just announced that its common shares have been made eligible for book-entry and depository services of the Depository Trust Company to facilitate electronic clearing and settlement of transfers of its common shares in the United States. DTC eligibility is expected to simplify the process of trading and the transferring of Xebra’s shares and will enhance liquidity in the United States because of the accelerated settlement period and the expected reduction in costs for investors and brokers, enabling trading over a wider selection of brokerage firms. "Receiving DTC eligibility, is an important milestone for Xebra, and is part of our commitment to increase corporate visibility while positioning U.S. investors to participate in Xebra’s growth," said Rodrigo Gallardo, President of Xebra. DTC is a subsidiary of the Depository Trust & Clearing Corporation, a United States company that manages electronic clearing and settlement for publicly traded companies. Securities that are eligible to be electronically cleared and settled through the DTC are considered to be "DTC eligible." Other related developments from around the markets include: Aurora Cannabis, the Canadian company defining the future of cannabinoids worldwide, announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021. "During the second quarter, we improved our Adjusted EBITDA by $2.5 million over Q1, moving us closer to our profitability goal. Our focus remains on further cost reductions, and we are pleased to announce today that we expect to reach the high end of the $60 to $80 million range. Our balance sheet remains among the strongest in the industry, with approximately $445 million in cash as of yesterday. This gives us significant working capital to support organic growth and positions us to pursue strategic M&A opportunities," stated Miguel Martin, Chief Executive Officer of Aurora. Canopy Growth announced its financial results for the third quarter fiscal 2022 ended December 31, 2021. “In the third quarter we actioned to win where it matters – driving record performance in our CPG business from both BioSteel and Storz & Bickel, while beginning to stabilize our Canadian business including maintaining the #1 position in premium flower. Our continued discipline and focus are expected to fortify Canopy’s competitive positioning in Canada as we ambitiously build our U.S. CPG, CBD, and THC strategies,” said David Klein, CEO. Tilray Inc., a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, announced that its medical cannabis division, Tilray Medical, has completed its first sale of medical cannabis in Malta. Tilray’s EU-GMP medical cannabis products are now available in pharmacies across Malta, providing patients with safe and reliable access to high-quality medical cannabis. Denise Faltischek, Tilray’s Chief Strategy Officer and Head of International Business, said, “As demand for cannabis continues to grow across Europe, we’re incredibly proud to partner with established and reliable distribution partners to supply new markets with high-quality medical cannabis which patients can rely on.” OrganiGram Holdings announced its results for the first quarter ended November 30, 2021. “Our record-breaking results in the first quarter of Fiscal 2022 are a testament to our successful strategy to create innovative, high-quality products that align with the evolving preferences of the various segments of cannabis consumers,” said Beena Goldenberg. “Our positive outlook for 2022 is further bolstered by the addition of Laurentian’s premium products to our portfolio, with an increased presence in Quebec and the resumption of international sales, which will continue through the year.” Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Xebra Brands has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of Xebra Brands. Click here for disclaimer. Contact Information: 2818047972 [email protected]
Mexico is One Step Closer to Cannabis Regulation in 2022 March 01, 2022 - Baystreet.ca Mexico may be closer to cannabis regulation. While 2021 ended the Mexican Senate passing new cannabis laws, “the President of the Mexican Senate Olga Sánchez Cordero Dávila tweeted hat she was ready to move forward with marijuana regulation along with a number of other priorities during the current legislative session. “We will work to approve the initiatives that we have presented in matters of cannabis regulation,” as quoted by The Paper. She added, “I have just been informed that even Thailand, in the Asian countries, has already approved the regulation of cannabis. Of course, already in many other countries they are regulating it, and we do not want to be left behind,” as quoted by Mugglehead Magazine. With Mexico nearing potential legislation, it could be a substantial catalyst for Xebra Brands (CSE:XBRA) (OTCQB:XBRAF), Aurora Cannabis (NASDAQ:ACB) (TSX:ACB), Canopy Growth (TSX:WEED)(NASDAQ:CGC), Tilray Inc. (NASDAQ:TLRY)(TSX:TLRY), and OrganiGram Holdings (NASDAQ:OGI)(TSX:OGI). Look at Xebra Brands (CSE:XBRA)(OTCQB:XBRAF), For Example Xebra Brands Ltd., just announced that its common shares have been made eligible for book-entry and depository services of the Depository Trust Company to facilitate electronic clearing and settlement of transfers of its common shares in the United States. DTC eligibility is expected to simplify the process of trading and the transferring of Xebra’s shares and will enhance liquidity in the United States because of the accelerated settlement period and the expected reduction in costs for investors and brokers, enabling trading over a wider selection of brokerage firms. "Receiving DTC eligibility, is an important milestone for Xebra, and is part of our commitment to increase corporate visibility while positioning U.S. investors to participate in Xebra’s growth," said Rodrigo Gallardo, President of Xebra. DTC is a subsidiary of the Depository Trust & Clearing Corporation, a United States company that manages electronic clearing and settlement for publicly traded companies. Securities that are eligible to be electronically cleared and settled through the DTC are considered to be "DTC eligible." Other related developments from around the markets include: Aurora Cannabis, the Canadian company defining the future of cannabinoids worldwide, announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021. "During the second quarter, we improved our Adjusted EBITDA by $2.5 million over Q1, moving us closer to our profitability goal. Our focus remains on further cost reductions, and we are pleased to announce today that we expect to reach the high end of the $60 to $80 million range. Our balance sheet remains among the strongest in the industry, with approximately $445 million in cash as of yesterday. This gives us significant working capital to support organic growth and positions us to pursue strategic M&A opportunities," stated Miguel Martin, Chief Executive Officer of Aurora. Canopy Growth announced its financial results for the third quarter fiscal 2022 ended December 31, 2021. “In the third quarter we actioned to win where it matters – driving record performance in our CPG business from both BioSteel and Storz & Bickel, while beginning to stabilize our Canadian business including maintaining the #1 position in premium flower. Our continued discipline and focus are expected to fortify Canopy’s competitive positioning in Canada as we ambitiously build our U.S. CPG, CBD, and THC strategies,” said David Klein, CEO. Tilray Inc., a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, announced that its medical cannabis division, Tilray Medical, has completed its first sale of medical cannabis in Malta. Tilray’s EU-GMP medical cannabis products are now available in pharmacies across Malta, providing patients with safe and reliable access to high-quality medical cannabis. Denise Faltischek, Tilray’s Chief Strategy Officer and Head of International Business, said, “As demand for cannabis continues to grow across Europe, we’re incredibly proud to partner with established and reliable distribution partners to supply new markets with high-quality medical cannabis which patients can rely on.” OrganiGram Holdings announced its results for the first quarter ended November 30, 2021. “Our record-breaking results in the first quarter of Fiscal 2022 are a testament to our successful strategy to create innovative, high-quality products that align with the evolving preferences of the various segments of cannabis consumers,” said Beena Goldenberg. “Our positive outlook for 2022 is further bolstered by the addition of Laurentian’s premium products to our portfolio, with an increased presence in Quebec and the resumption of international sales, which will continue through the year.” Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Xebra Brands has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of Xebra Brands. Click here for disclaimer. Contact Information: 2818047972 [email protected]